Showing 181 - 200 results of 640 for search '(( significant fold decrease ) OR ( significant decrease decrease ))~', query time: 0.34s Refine Results
  1. 181
  2. 182
  3. 183

    Differential expression patterns and functional gene groups associated with SARS-CoV-2 infection of nose organoids. by Vasanthi Avadhanula (259546)

    Published 2025
    “…<b>(c)</b> Similar to part b, but for genes decreased with SARS-CoV-2 infection. <b>(d)</b> Selected significantly enriched GO terms <sup>41</sup> within the genes over-expressed with SARS-CoV-2 infection in HNO204 (p<0.05, t-test). …”
  4. 184
  5. 185
  6. 186
  7. 187

    Exclusion and enrollment summary from NHANES. by Lu Han (151620)

    Published 2025
    “…Individuals under 30 showed no significant differences. A unit increase below 9.30 in Log2-PMR reduced HCV risk by 0.60-fold. …”
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    Normality test using the Shapiro-Wilk test. by Akinaka Morii (12709672)

    Published 2025
    “…The area of cardiac fibrosis was significantly increased (approximately 3.6-fold) and the number of apoptotic myocytes was significantly increased (approximately 7.7-fold) in the heart of the PG-LPS-treated group versus the control, and these changes were suppressed by allopurinol. …”
  14. 194

    Minimal data set. by Ikuo Mikoshiba (9312007)

    Published 2025
    “…Results indicated that both the DFAT and DFAT + bFGF groups exhibited significantly reduced glottic gaps, increased collagen deposition, and decreased TUNEL-positive apoptotic cells compared to controls. …”
  15. 195
  16. 196
  17. 197
  18. 198

    Descriptive characteristics of the sample. by Ronna Bañada (19233063)

    Published 2024
    “…During the first year of the pandemic, symptoms of depression and anxiety increased seven-fold within Asian Pacific Islander Desi American (APIDA) communities. …”
  19. 199

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …”
  20. 200